Research report

Kidney Transplant Market by Country (United States, Germany, France, Italy, United Kingdom, Japan, Argentina, Mexico, Spain, Brazil) Analysis and Forecast to 2021

Format : Pdf

Publish Date: 17th October 2016

Pages: 95

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.

Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.


Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share.United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.


Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France.  Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share. 


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.


The 10 countries covered in the report are analysed from two viewpoints:


1. Number of Kidney Transplant Performed (2008 - 2021) 

2. Kidney Transplant Market (2008 - 2021) 


Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:


1.    United States

2.    Germany

3.    France

4.    Italy

5.    United Kingdom

6.    Japan

7.    Argentina

8.    Mexico

9.    Spain

10.  Brazil


Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows


1.    Cellcept (Mycophenolate Mofetil)

2.    Prograf(Tacrolimus)

3.    Rapamune (Sirolimus)

4.    Myfortic (Mycophenolic Acid)

5.    Neoral / Sandimmune (Cyclosporine)

6.    Zortress / Certican (Everolimus)


Research Methodology


DPI Research’s team of researchers and analysts use a variety of research sources for making a report. Most of the data – information and statistics – for our products is gathered using the secondary research by our in–house team of researchers. The main objective of DPI Research’s secondary research exercise is to exhaust all sources of published information including websites of government agencies, consumer and trade associations, annual reports and accounts of companies, news articles from well–known publications and online databases like Factiva, OneSource, Thomson, Hoovers, etc. The data thus gathered is send to our team of analysts who verify that data and look for research gaps. These gaps are filled through primary research, that is, our analysts gain information from various agencies, associations and companies using customer surveys, telephonic and email interviews, etc. Finally, all the information collected using secondary and primary research is analysed and synthesized by our analysts and is presented in a report.


Industry information and data for this report has been sourced through numerous channels including publically available information from companies’ and industry association websites. For industry sizing, segmentation and trends, apart from desk research, we have contacted industry experts and executives from various companies.


Market forecasts are done using statistical forecasting techniques based on historic performance. Statistical tools are further supplemented with qualitative parameters like industry expectation, economic drivers, new product development, customer surveys, ongoing research, etc.


All the information gathered was then analysed and synthesized by our in–house team of analysts.


1. Executive Summary

2. United States - Top Kidney Transplant Centres

3. 10 Major Markets - Kidney Transplant Number, Market Outlook

3.1 10 Major Markets - Kidney Transplant Number & Forecast
3.2 10 Major Markets - Kidney Transplant Market & Forecast

4. 10 Major Markets - Kidney Transplant Number, Market Share Outlook

4.1 Kidney Transplant Number Share & Forecast
4.2 Kidney Transplant Market Share & Forecast

5. Kidney Transplant Market – Top 10 Country Analysis (2008 – 2021)
 
5.1 United States
5.1.1 United States – Number of Kidney Transplant & Forecast
5.1.2 United States – Kidney Transplant Market & Forecast
5.2 Germany
5.2.1 Germany – Number of Kidney Transplant & Forecast
5.2.2 Germany – Kidney Transplant Market & Forecast
5.3 France
5.3.1 France – Number of Kidney Transplant & Forecast
5.3.2 France – Kidney Transplant Market & Forecast
5.4 Italy
5.4.1 Italy – Number of Kidney Transplant & Forecast
5.4.2 Italy – Kidney Transplant Market & Forecast
5.5 United Kingdom
5.5.1 United Kingdom – Number of Kidney Transplant & Forecast
5.5.2 United Kingdom – Kidney Transplant Market & Forecast
5.6 Japan
5.6.1 Japan – Number of Kidney Transplant & Forecast
5.6.2 Japan – Kidney Transplant Market & Forecast
5.7 Argentina
5.7.1 Argentina – Number of Kidney Transplant & Forecast
5.7.2 Argentina – Kidney Transplant Market & Forecast
5.8 Mexico
5.8.1 Mexico – Number of Kidney Transplant & Forecast
5.8.2 Mexico – Kidney Transplant Market & Forecast
5.9 Spain
5.9.1 Spain – Number of Kidney Transplant & Forecast
5.9.2 Spain – Kidney Transplant Market & Forecast
5.10 Brazil 
5.10.1 Brazil – Number of Kidney Transplant & Forecast
5.10.2 Brazil Kidney Transplant Market & Forecast

6. Key Development in Kidney Transplant Market

6.1 Year 2016

7. Organ Transplantation Immunosuppressive/Rejection Drugs Analysis

7.1 Cellcept (Mycophenolate Mofetil) 
7.1.1 CellCept (Mycophenolate Mofetil) Drugs Sales & Forecast
7.2 Prograf(Tacrolimus) 
7.2.1 Prograf (Tacrolimus) Drug Sales & Forecast
7.3 Rapamune (Sirolimus) 
7.3.1 Rapamune (Sirolimus) Drug Sales & Forecast
7.4 Myfortic (Mycophenolic Acid) 
7.4.1 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
7.5 Neoral / Sandimmune (Cyclosporine) 
7.5.1 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
7.6 Zortress / Certican (Everolimus) 
7.6.1 Zortress / Certican (Everolimus) Drug Sales & Forecast

8. Kidney Transplant Market – Growth Drivers

9. Kidney Transplant Market – Challenges

List of Tables:

Table 3–1: Number of Kidney Transplant(Percent),2008 – 2015
Table 3–2: Forecast for Number of Kidney Transplant(Percent),2016 – 2021
Table 3–3: Kidney Transplant Market Share(Percent),2008 – 2015
Table 3–4:  Forecast for Kidney Transplant Market Share (Percent),2016 – 2021

List of Figures:

Figure 2 1: Number of Kidney Transplant(Number), 2008 – 2015
Figure 2 2: Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 2 3: Kidney Transplant Market (Million US$), 2008 – 2015
Figure 2 4: Forecast for Kidney Transplant Market (Million US$), 2016 – 2021

Figure 4 1: United States – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 2: United States – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 3: United States – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 4:United States – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 5: Germany – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 6: Germany – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 7: Germany – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 8: Germany – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 9: France – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 10: France – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 11: France – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 12: France – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 13: Italy – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 14: Italy – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 15: Italy – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 16: Italy – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 17: United Kingdom – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 18: United Kingdom – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 19: United Kingdom – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 20: United Kingdom – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 21: Japan – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 22: Japan – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 23: Japan – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 24: Japan – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 25: Argentina – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 26: Argentina – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 27: Argentina – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 28: Argentina – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 29: Mexico – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 30: Mexico – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 31: Mexico – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 32: Mexico – Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure  4 33: Spain – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 34: Spain – Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 35: Spain – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 36: – Spain –  Forecast for Kidney Transplant Market (Million US$), 2016 – 2021
Figure 4 37: Brazil – Number of Kidney Transplant(Number), 2008 – 2015
Figure 4 38: – Brazil Forecast for Number of Kidney Transplant(Number), 2016 – 2021
Figure 4 39: Brazil – Kidney Transplant Market (Million US$), 2008 – 2015
Figure 4 40: – Brazil –  Forecast for Kidney Transplant Market (Million US$), 2016 – 2021

Figure 5 1: Worldwide – CellCept Drug Sales (Million US$), 2008 – 2015
Figure 5 2: Worldwide – Forecast for CellCept Drug Sales (Million US$), 2016 – 2021
Figure 5 3: Worldwide – Prograf Drug Sales (Million US$), 2009 – 2015
Figure 5 4: Worldwide – Forecast for Prograf Drug Sales (Million US$), 2016 – 2021
Figure 5 5: Worldwide – Rapamune Drug Sales (Million US$), 2009 – 2015
Figure 5 6: Worldwide – Forecast for Rapamune Drug Sales (Million US$), 2016 – 2021
Figure 5 7: Worldwide – Myfortic Drug Sales (Million US$), 2008 – 2015
Figure 5 8: Worldwide – Forecast for Myfortic Drug Sales (Million US$), 2016 – 2021
Figure 5 9: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2008 – 2015
Figure 5 10: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2016 – 2021
Figure 5 11: Worldwide – Zortress/Certican Drug Sales (Million US$), 2008 – 2015
Figure 5 12: Worldwide – Forecast for Zortress / Certican Drug Sales (Million US$), 2016 – 2021

Figure 9 1: United States – Number of Kidney Living Donor (Number), 2011 – 2015